Zoetis Inc. (NYSE: ZTS) the world’s leading animal health company, announces it has entered into a definitive agreement with Neogen Corporation (NASDAQ: NEOG) (“Neogen”) to acquire Neogen’s animal genomics business for $160 million, subject to customary closing adjustments. This acquisition aligns directly with Zoetis’ strategy to drive future livestock innovation through genomics, reinforcing its commitment to livestock producers worldwide and advancing its Precision Animal Health portfolio. Neogen’s genomics business serves customers in more than 120 countries through its five laboratories in the United States, Brazil, Australia, China and the United Kingdom, as well as an office location in Canada.
Read the full article: Zoetis to Acquire Animal Genomics Business from Neogen®, Accelerating Precision Animal Health Innovation //
Source: https://www.businesswire.com/news/home/20260227496705/en/Zoetis-to-Acquire-Animal-Genomics-Business-from-Neogen-Accelerating-Precision-Animal-Health-Innovation